Industry Responds to the UK Gov’s Levelling Up White Paper

The Association of the British Pharmaceutical Industry (ABPI) has responded to the publication of a white paper on ‘Levelling Up’ by the government of the United Kingdom, in a statement released on Feb. 2, 2022.

The aim of the Levelling Up white paper is to provide details on how the government plans to spread out opportunity more equally within the UK by the year 2030. According to Richard Torbett, chief executive of the ABPI, it is essential that the country’s life sciences’ sector is strong to aid with levelling up.

“The sector is already represented in every region across the UK, but by backing life sciences—and through the creation of highly-skilled, well-paid jobs in science, R&D and manufacturing—there is even greater potential for the life sciences to help level up the UK,” Torbett said in the press release. “The commitment to close the healthy life expectancy gap by 2030 is particularly important. To close this gap and transform the lives of patients, we need to make sure that people can access the best possible care wherever they live in the UK. Getting this right must be central to the missions set out today.”